Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia 6Wilms Tumor 3Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Sarcoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Kidney Neoplasms 2Glioblastoma 2Central Nervous System Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Squamous Intraepithelial Lesions 1Rectal Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Melanoma 1Gliosarcoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognition Disorders 1Brain Neoplasms 1Astrocytoma 1Anus Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Temozolomide 14Radiotherapy 8Vincristine 5Procarbazine 3Lomustine 3lonafarnib 2imetelstat 2Topotecan 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Irinotecan 2Carboplatin 2veliparib 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1palbociclib 1emvododstat 1azurin (50-77) 1Vinblastine 1Semaxinib 1Neoadjuvant Therapy 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Imatinib Mesylate 1GRN163L peptide 1Dexamethasone 1DNA Methylation 1Chemotherapy, Adjuvant 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Oligodendroglioma × DNA Methylation × Clear all
NCT00626990 2023-09-11

CATNON

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
751 enrolled 18 charts
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡